Assessment of baseline characteristics indicated that patients with recurrence had higher proportions of non-paroxysmal atrial fibrillation and higher levels of serum galectin-3 compared to patients without recurrence (Fig. 3). The gene discussed is LGALS3; the disease is Paroxysmal atrial fibrillation.